Skip to main content
INNV
NASDAQ Industrial Applications And Services

InnovAge Q1 FY2027: Revenue Up 12.1% to $264.8M, Net Income Triples to $20.9M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.85
Mkt Cap
$1.208B
52W Low
$3.935
52W High
$12.64
52W Position info
125% above low
Off High info
30% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

INNV has more than doubled off its 52-week low of $3.935.

Summary

InnovAge opened fiscal 2027 with revenue up 12.1% to $264.8M and net income of $20.9M versus $7.7M a year ago, and confirmed its full-year revenue and Adjusted EBITDA guidance.


Key Events · Earnings and Guidance · INNV

  • Q1 Revenue Grows 12.1%

    Total revenues came in at $264.8M versus $236.1M in the first quarter of fiscal 2026, with census up to approximately 8,420 participants from 7,890.

  • Net Income Nearly Triples

    Net income of $20.9M, or $0.14 per diluted share, versus $7.7M and $0.06 a year ago; net income margin rose to 7.9% from 3.2%.

  • Adjusted EBITDA Jumps to $31.3M

    Adjusted EBITDA of $31.3M (11.8% margin) versus $17.6M (7.5% margin), a $13.6M increase; center-level contribution margin rose 23.8% to $63.6M.

  • FY2027 Guidance Confirmed

    Revenue guidance of $1.050B-$1.085B and Adjusted EBITDA of $105M-$115M reaffirmed as of November 3, 2026.


Analysis · INNV · Industrial Applications And Services

The margin story is finally landing. Revenue grew 12.1% to $264.8M, net income nearly tripled to $20.9M, and Adjusted EBITDA jumped to $31.3M from $17.6M — an 11.8% Adjusted EBITDA margin versus 7.5% a year ago. Census rose to roughly 8,420 participants from 7,890. Management confirmed full-year FY2027 guidance of $1.050B-$1.085B in revenue and $105M-$115M in Adjusted EBITDA, so the quarter is tracking the plan rather than forcing a raise or a cut. The balance sheet is comfortable for this business — $119.3M cash plus $43.7M short-term investments against $61.4M of debt — which matters given the $37M litigation accrual disclosed in the prior 10-K. One structural change: starting this fiscal year, prepared remarks emphasize year-over-year rather than sequential comparisons, making the growth rate the number to judge them on going forward.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INNV was trading at $8.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $3.94 to $12.64. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INNV - Latest Insights

INNV
Nov 03, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.14 info
Change: +$0.290 (+3%) info
Market Cap: $1.251B info
INNV
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.14 info
Change: +$0.290 (+3%) info
Market Cap: $1.251B info
INNV
Sep 23, 2026, 2:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.14 info
Change: -$0.510 (-5%) info
Market Cap: $1.251B info
INNV
Sep 22, 2026, 5:19 PM EDT
Filing Type: 424B7
Importance Score:
7
Price at Filing: $9.51
Real-time Price: $9.14 info
Change: -$0.370 (-4%) info
Market Cap: $1.251B info
INNV
Sep 22, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $10.10
Real-time Price: $9.14 info
Change: -$0.960 (-10%) info
Market Cap: $1.251B info